THIS IS A DRAFT RELEASE

The Research, Surveillance, Science and Current News provides new publications and data releases on substance use and harms for the month of MONTH 2023 with a focus on epidemiological and statistical disciplines.

Data Releases from Canada

Releases from Federal Government

Health Canada’s Drug Analysis Service

  • The emergence of Xylazine in Canada indicating that Xylazine
  • First identified in Canada in 2001 in exhibits submitted by law enforcement agencies and emerging in 2019, had 5 identifications 2018, in-creasing to 205 in 2019, and between January 2012 and December 2022, Xylazine has been identified in 2,324 exhibits submitted to DAS.

Health Canada’s Drug Analysis Service

  • The evolution of Fentanyl in Cana-da over the past 11 years
  • Indicating that Fentanyl, first identified in Canada in 1989 exhibits submitted to DAS by law enforcement, has seen a sharp increase; between January 2012 and December 2022, Fentanyl has been identified in 77,141 exhibits.

Statistics Canada

  • Exploring the intersectionality of characteristics among those who experi-enced opioid overdoses: A cluster analysis
  • Results reveal a six-cluster solution identifying characteris-tics of those experiencing overdose.
  • Application of machine learning techniques to a multidimensional database enables an intersectional approach to study those experiencing opioid over-doses.
  • The results revealed distinct patient profiles that can be used to better target interventions and treatment.

Releases from Provence and Territories

BC Coroners Service – January 2023 Release:

  • There were 211 suspected illicit drug deaths, which represents a 2% decrease (216) over the number in January 2022 and a 2% increase (207) over December 2022.

Releases from NGOs

Center on Drug Policy Evaluation

  • Toronto’s Drug Checking Service sample results for February 25 – March 10, 2023
  • Key findings include 7% of the expected fentanyl samples were known to be associated with an overdose.
  • All contained fentanyl and almost all contained other high-potency opioids, like carfentanil (up to 100 times stronger than fentanyl) or fluorofentanyl (roughly as strong as fentanyl), and benzodiazepine-related drugs.

Canadian Center on Substance Use and Addiction

  • Canadian Substance Use Costs and Harms 2007–2020

  • Substance use led to $13.4 billion in healthcare costs in 2020 or 27.3% of the overall cost of $49.1 billion (alcohol $6.3B; opioids $519M), and nearly 74,000 deaths in 2020. While per-person healthcare costs attributable to alcohol rose 40.5% between 2007 and 2020 (from $117 to $165), per-person healthcare costs associated with tobacco use decreased 14.5% (from $167 to $143).

International Data Releases

The United Nations

The United Nations Office on Drugs and Crime

Peer Reviewed Journals

Canadian Studies

No updates

International Studies

Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town

  • Examines the impacts of COVID-19 pandemic on drug use in a rural community using a two-year wastewater-based drug use surveillance from September 2018 to August 2020.

  • Analysis for ten priority opioids and stimulants found all target drugs were detected at 100 % frequency in wastewater samples, and per capita consumption of fentanyl was higher than previous reports.

  • The results demonstrate the utility and strength of wastewater-based approaches in capturing long-term and evolving trends in drug use within communities and provide objective data and insights for health policymakers on the effects of the pandemic period on community drug use in a rural U.S. town.
Racial and Ethnic Differences in Deaths by Suicide, Drug Overdose, and Opioid-Related Overdose in a National Sample of Military Members With Mild Traumatic Brain Injury, 1999-2019

  • Examined racial and ethnic differences in suicide and drug and opioid-related overdose deaths among a population-based cohort of military service members who were diagnosed with a mild traumatic brain injury (mTBI) during military service.

  • Age-specific rates for military members who self-identified as Other were higher than all other racial/ethnic groups for all 3 mortality outcomes; adjusting for age, suicide rates for those classified as “Other” were up to 5 times that of other racial/ethnic groups for suicide, and up to 11 and 3.5 times that of other race/ethnicity groups for drug and opioid overdose death, respectively, highlighting new areas for understanding the impact of race and ethnicity on mortality.
Alcohol use and treatment utilization in a national sample of veterans and nonveterans

  • Compared prevalence of alcohol use problems and alcohol treatment utilization between veterans and nonveterans and whether predictors of alcohol use problems and alcohol treatment utilization differ in veterans vs. nonveterans.

  • Population weighted regression models demonstrated that veterans reported modestly higher alcohol consumption than nonveterans, but were not significantly more likely to need intensive alcohol treatment.

  • Veterans may benefit from interventions with social and financial support to reduce alcohol problems; these findings can help to identify veterans and nonveterans who are more likely to need treatment.

We would love to hear from you! Please take three minutes to fill out feedback survey.